Boussard & Gavaudan Investment Management »

Cytokinetics shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 6.4k 1615.32

More positions owned by Boussard & Gavaudan Investment Management

Pioneer Natural Resources (PXD)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Hess (HES)
Booking Holdings Note 0.750% 5/0
Altair Engr Note 0.250% 6/0
United States Steel Corporation (X)
Liberty Media Corp Del Com Lbty Srm S A (LSXMA)
Axon Enterprise Note 0.500%12/1
Westrock (WRK)
Akamai Technologies Note 0.125% 5/0
Capri Holdings SHS (CPRI)
Integer Hldgs Corp Note 2.125% 2/1
Zscaler Note 0.125% 7/0
Dynavax Technologies Corp Note 2.500% 5/1
Freshpet Note 3.000% 4/0

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Cytokinetics

Wolverine Asset Management
Citadel Advisors
Balyasny Asset Management
D. E. Shaw & Co
Polygon Management
FMR
Sona Asset Management
DeepCurrents Investment Group
Millennium Management
Point72 Asset Management
Partner Fund Management
Flow State Investments
Ameriprise Financial
Morgan Stanley
Verition Fund Management

View all funds holding Cytokinetics